If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password
If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password
Corrigendum to ‘Health-related quality of life in patients with advanced well-differentiated pancreatic and extrapancreatic neuroendocrine tumors treated with surufatinib versus placebo: Results from two randomized, double-blind, phase III trials (SANET-p and SANET-ep)’ [European Journal of Cancer 169 (2022) 1–9]
Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China
Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China
Department of Gastric Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
The authors regret there were mistakes in two figures for the wrong direction of functional scales. High scores for functional scales represent high or healthy level of functioning, but the original direction is opposite. These mistakes were found in Figure 2A, Figure 2C, Figure 3A, Figure 3C, and their figure legends. The outcome results are not affected.
The corrected figures and figure legends are given here.
Figure 2Mean change scores for QLQ-C30 and QLQ-G.I.NET21 scales from baseline to the last available visit. (A) Global health status and functioning scales of QLQ-C30 (B) symptom scales of QLQ-C30 (C) functioning scales of QLQ-G.I.NET21 (D) symptom scales of QLQ-G.I.NET21.
Figure 3 Mean change scores for QLQ-C30 and QLQ-G.I.NET21 scales from baseline to the week 16. (A) Global health status and functioning scales of QLQ-C30 (B) symptom scales of QLQ-C30 (C) functioning scales of QLQ-G.I.NET21 (D) symptom scales of QLQ-G.I.NET21.
00779-1&id=fx1.jpg){kind=link}
00779-1&id=fx2.jpg){kind=link}